CPAP Devices Can Be Used as Ventilators During Coronavirus Outbreak, FDA Guidance Says

Published in Member Communities on March 24, 2020

On March 22, it was announced that new temporary guidance from the FDA allows hospitals to re-purpose existing products such as CPAP devices as ventilators in an effort to meet major shortages in the United States during the coronavirus outbreak.

The guidance allows hospitals and manufacturers to make certain modifications to existing devices, or to production lines, to create more respiratory devices.

Ventilators normally used in other environments, such as ambulances, could be used for long-term care, the guidance says. It covers devices that aren't traditionally used for long-term care.

The guidance also would allow non-medical device companies, such as auto manufacturers, to start making ventilator parts.

The agency plans to use "enforcement discretion" for modifications to FDA-cleared devices. Traditionally manufacturers' modifications to ventilators would trigger an additional pre-market review, which could delay deployment.

The guidance means "America can make more ventilators during this crisis,” Health and Human Services Secretary Alex Azar said in a release.

The guidance also aims to create "maximum regulatory flexibility" while "still providing crucial FDA oversight," FDA Commissioner Stephen Hahn said in a release.

FDA is also encouraging manufacturers, including foreign ones, to contact the agency about emergency authorizations to distribute ventilators in the United States.

Original Updates:

 

From Our Experts

A Letter From the President: May 2025 thumbnail A Letter From the President: May 2025 Lindy Tentinger shares information on VGM Heartland Conference, operational efficiency, diversification of revenue streams, and more. Heartland Zeroes in on Cybersecurity, AI thumbnail Heartland Zeroes in on Cybersecurity, AI With cyberattacks escalating and AI innovation, VGM's Heartland Conference is expanding its focus on digital preparedness. VGM & Associates Releases Playbook on Cost of Doing Business thumbnail VGM & Associates Releases Playbook on Cost of Doing Business “VGM Playbook: Cost Management Trends, Strategies, and Solutions,” is designed to help VGM members optimize healthcare operations and manage costs effectively. Heartland Preview: New Tracks, Plus Return of Keynote & Pre-Conference thumbnail Heartland Preview: New Tracks, Plus Return of Keynote & Pre-Conference It's not just another year for the 2025 VGM Heartland Conference – it's a handoff, a love letter to the small-town Midwest conference and a map for the industry's future. The Impact of HHS Cuts to the ACL on the Limb Loss Community and O&P Industry thumbnail The Impact of HHS Cuts to the ACL on the Limb Loss Community and O&P Industry As we navigate the evolving landscape of healthcare policy, I want to address a critical issue that directly affects both the limb loss community and the orthotics and prosthetics (O&P) industry. Achieving Results That Matter: Insights for HME Providers thumbnail Achieving Results That Matter: Insights for HME Providers This article explores strategies for achieving sustainable growth. OPGA, Össur Name Recipients of O&P Grants thumbnail OPGA, Össur Name Recipients of O&P Grants Avery-Claire Littleton and Nicole Bakovich have been selected as the recipients of two O&P grants. Adventure and Connections Await at Heartland 2025 thumbnail Adventure and Connections Await at Heartland 2025 This year's Heartland Conference promises an exciting lineup of activities designed to foster connections, inspire innovation, and create lasting memories.